AzTrials
AzTrials

Intraocular PressureNCT03938402

Intraocular Pressure and Optic Nerve Sheath Diameter Changes at Different PEEP Levels

A study testing Positive end-expiratory pressure in people with Intraocular Pressure and Intracranial Pressure, run by Marmara University at 1 site in Turkey (Türkiye).

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Positive end-expiratory pressure (PEEP) is sometimes used during perioperative period, as it has favourable effects on lung mechanics. Unfortunately, it has some negative effects on the patients, like increased intraabdominal, intrathoracic, intracranial and intraocular pressures. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
Positive end-expiratory pressure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jul 2019to 31 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients undergoing laparotomy for gastrointestinal surgery
  • American Society of Anesthesiologists (ASA) 1 or 2 physical status
  • Elective surgery

Who cannot join

  • Patients with glaucoma
  • ASA 3 or over physical status
  • Emergency surgery

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Marmara University School of Medicine

    Istanbul, Pendik, 34899

Other trials in Turkey (Türkiye)

About this study

Official title: Intraocular Pressure and Optic Nerve Sheath Diameter Changes at Different Positive End-expiratory Pressure Applications in Laparotomic Surgery

Positive end-expiratory pressure (PEEP) is sometimes used during perioperative period, as it has favourable effects on lung mechanics. Unfortunately, it has some negative effects on the patients, like increased intraabdominal, intrathoracic, intracranial and intraocular pressures. In this study the investigators aimed to investigate the effects of different PEEP levels on the patients' intraocular and intracranial pressures. Intraocular pressure will be measured by ocular tonometry, and intracranial pressure will be estimated by optic nerve sheath diameter measurement. The measurements will be performed in the operating room in the patients undergoing laparotomic surgery.

Being tested
Positive end-expiratory pressure
Keywords
Intraocular pressure, Optic nerve sheath diameter, Positive end-expiratory pressure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Positive end-expiratory pressureOther

    Different levels of positive end-expiratory pressure (i.e., 5, 10 and 15 cm H2O) will be applied to the groups.

Study groups in NCT03938402
Study groupRoleWhat they receive
PEEP 5ExperimentalNot described
Receives: Other: Positive end-expiratory pressure
PEEP 10ExperimentalNot described
Receives: Other: Positive end-expiratory pressure
PEEP 15ExperimentalNot described
Receives: Other: Positive end-expiratory pressure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in intraocular pressure

    The physiological value for intraocular pressure is 10-20 mm Hg. Changes in intraocular pressure will be observed throughout the surgery, as will its relationship with the positive end-expiratory pressure application.

    Measured: Throughout the operation (usually about 1.5 hours).

  2. Changes in optic nerve sheath diameter

    Changes in optic nerve sheath diameter will be observed throughout the surgery, as will its relationship with the positive end-expiratory pressure application.

    Measured: Throughout the operation (usually about 1.5 hours).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 May 2019
  2. Study start1 Jul 2019
  3. Primary completion31 Dec 2020
  4. Study completion31 Dec 2020

Why it stopped: As a result of COVID-19 pandemics

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03938402
Sponsor's protocol ID
09.2019.378
Status last verified
Nov 2021
First submitted
27 Apr 2019
Last updated
3 Dec 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Positive end-expiratory pressure in people with Intraocular Pressure and Intracranial Pressure, run by Marmara University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 3 Dec 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: As a result of COVID-19 pandemics). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in intraocular pressure (time frame: Throughout the operation (usually about 1.5 hours).). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Dec 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in